Pangaea Oncology, S.A. (BME:PANG)
Spain · Delayed Price · Currency is EUR 1.700
-0.050 (-2.86%)
Oct 7, 2025, 12:00 PM CET
Pangaea Oncology Market Cap
Pangaea Oncology has a market cap or net worth of €60.12 million as of October 7, 2025. Its market cap has decreased by -1.41% in one year.
Market Cap
60.12M
Enterprise Value
62.80M
Revenue
14.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.70
Market Cap Chart
Since December 29, 2016, Pangaea Oncology's market cap has increased from 30.03M to 60.12M, an increase of 100.23%. That is a compound annual growth rate of 8.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 60.12M | -1.13% |
| Dec 31, 2024 | 60.81M | 12.24% |
| Dec 29, 2023 | 54.18M | 8.35% |
| Dec 30, 2022 | 50.00M | 41.34% |
| Dec 30, 2021 | 35.38M | 30.94% |
| Dec 31, 2020 | 27.02M | -5.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 7.27B |
| Laboratorios Farmaceuticos Rovi | 3.09B |
| Almirall | 2.58B |
| Pharma Mar | 1.57B |
| Faes Farma | 1.35B |
| Clínica Baviera | 672.29M |
| Oryzon Genomics | 263.76M |
| Laboratorio Reig Jofre | 260.45M |